Clinical pharmacology and therapeutics
- Label
- Clinical pharmacology and therapeutics (literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi
- Reduction in hematocrit and hemoglobin following pioglitazone treatment is not hemodilutional in Type II diabetes mellitus (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Effect of pioglitazone on the metabolic and hormonal response to a mixed meal in type II diabetes (Articolo in rivista) (Prodotto della ricerca)
- Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome (Articolo in rivista) (Prodotto della ricerca)
- Effect of pioglitazone on the metabolic and hormonal response to a mixed meal in type 2 diabetes (Articolo in rivista) (Prodotto della ricerca)
- Alternative label
- Clin. pharmacol. ther. (literal)
- Clinical pharmacology and therapeutics. (literal)
- Clinical pharmacology & therapeutics (literal)
- Language
- eng (literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#issn
- 0009-9236 (literal)
- Preferred label
- Clinical pharmacology and therapeutics (literal)
- Publisher
- C.V. Mosby. St. Louis, USA (literal)
Incoming links:
- Rivista
- Effect of pioglitazone on the metabolic and hormonal response to a mixed meal in type II diabetes (Articolo in rivista) (Prodotto della ricerca)
- Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome (Articolo in rivista) (Prodotto della ricerca)
- Effect of pioglitazone on the metabolic and hormonal response to a mixed meal in type 2 diabetes (Articolo in rivista) (Prodotto della ricerca)
- Reduction in hematocrit and hemoglobin following pioglitazone treatment is not hemodilutional in Type II diabetes mellitus (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
